Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients
Status:
Completed
Trial end date:
2019-04-02
Target enrollment:
Participant gender:
Summary
The REaCT TAPS clinical trial will compare a tapering dose of dexamethasone to other
standards of care on the presence of taxane-associated pain syndrome (TAPS) in early stage
breast cancer.